Prolonged opioid use was less commonly observed among patients who were either Asian, earned $150,000 or more annually, or had undergone regional anesthesia.
Most patients treated with SPR Therapeutics' 60-day PNS therapy achieved clinically significant reductions in pain intensity, disability and pain interference.